Racial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: National health and nutrition examination survey 1999-2008

Journal of General Internal Medicine

Volumn 27, Issue 8, 2012, Pages 893-900

  Hunt, Kelly J ^a,b   Gebregziabher, Mulugeta ^a,b   Egede, Leonard E ^a,c  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cardio metabolic risk; Disparities; HbA1c; Undiagnosed diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTHRITIS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; SMOKING; STROKE;

ADULT; AFRICAN AMERICANS; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS;

EID: 84864475364     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2023-7     Document Type: Review

References (40)

1. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-139.
2. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559. (Pubitemid 351831356)
3. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. 2000;342(6):381-9. PMCID: 2630213.
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353 (25):2643-2653. PMCID: 2637991. (Pubitemid 41817713)
5. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321(7258):405-412. PMCID: 27454. (Pubitemid 30609442)
6. American Diabetes Association. Standards of medical care in diabetes- 2010. Diabetes Care. 2010;33 Suppl 1:S11-61. PMCID: 2797382.
7. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care.33(3):562-8.
8. Cowie C. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29(6):1263-1268. (Pubitemid 44125920)
9. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32(2):287-294.
10. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21(4):518-524.
11. Chaturvedi N, McKeigue PM, Marmot MG. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension. 1993;22(1):90-96. (Pubitemid 23187389)
12. Zoratti R, Godsland IF, Chaturvedi N, Crook D, Stevenson JC, McKeigue PM. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: Relevance to variation in risk of diabetes and coronary disease. Metabolism. 2000;49(2):245-252. (Pubitemid 30090892)
13. Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: An analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49(2):109-116. (Pubitemid 32207218)
14. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. Ametabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care. 1996;19(5):414-418. (Pubitemid 26143742)
15. Lackland DT, Orchard TJ, Keil JE, Saunders DE Jr, Wheeler FC, Adams-Campbell LL, et al. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? A survey in a biracial population. Int J Epidemiol. 1992;21(2):236-245.
16. Keil JE, Sutherland SE, Hames CG, Lackland DT, Gazes PC, Knapp RG, et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med. 1995;155(14):1521-1527.
17. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987;36(4):523-534. (Pubitemid 18023199)
18. Cooper RS, Liao Y, Rotimi C. Is hypertension more severe among U.S. blacks, or is severe hypertension more common? Ann Epidemiol. 1996;6 (3):173-180. (Pubitemid 26163142)
19. Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: Findings from the National Health and Nutrition Examination Survey 1999-2008*. J Diabetes. 2011;3(4):337-347.
20. Tull ES, Roseman JM. Diabetes in African Americans. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [NIH Publication No. 95-1468]; 1995. pp. 613-30.
21. Geiss LS, Herman WH, Smith P. Moratlity in non-insulin-dependant diabetes. In : National Diabetes Data Group, ed Diabetes in America: Bethesda, MD: US Dept of HEalth and Human Services, Public Health Service. National Institutes of Health; 1995. p. 233-57.
22. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2011 [updated 2011; cited 2011 04/05/2011]; Available from: Http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm.
23. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care. 2010;33(10):2184-2189. PMCID: 2945158.
24. Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care. 2011;34(1):84-89.
25. Boltri JM, Okosun IS, Davis-Smith M, Vogel RL. Hemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: Results from NHANES 1999-2000. Ethn Dis. 2005;15(4):562-567. (Pubitemid 41645121)
26. Twombly JG, Long Q, Zhu M, Wilson PW, Narayan KM, Fraser LA, et al. Diabetes care in black and white veterans in the southeastern U.S. Diabetes Care. 2010;33(5):958-963.
27. Fagot-Campagna A, Narayan KM, Hanson RL, Imperatore G, Howard BV, Nelson RG, et al. Plasma lipoproteins and incidence of non-insulindependent diabetes mellitus in Pima Indians: Protective effect of HDL cholesterol in women. Atherosclerosis. 1997;128(1):113-119. (Pubitemid 27065267)
28. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulinresistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: Implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101 (9):975-980. (Pubitemid 30131698)
29. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and noninsulin- dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990;131(3):443-453. (Pubitemid 20051740)
30. Medalie JH, Papier CM, Goldbourt U, Herman JB. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med. 1975;135(6):811-817.
31. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993;36(6):553-559. (Pubitemid 23161224)
32. Hunt KJ, Williams K, Rivera D, O'Leary DH, Haffner SM, Stern MP, et al. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol. 2003;23(10):1845-1850. (Pubitemid 37254873)
33. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes. 1994;43 (4):552-557. (Pubitemid 24096296)
34. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002;25(7):1129-1134. (Pubitemid 41071162)
35. Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care. 2008;46(3):287-292.
36. Nichols GA, Brown JB. Higher medical care costs accompany impaired fasting glucose. Diabetes Care. 2005;28(9):2223-2229. PMCID: 1383774. (Pubitemid 41242472)
37. Koopman RJ, Mainous AG, 3 rd, Liszka HA, Colwell JA, Slate EH, Carnemolla MA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med. 2006;4(5):427-32. PMCID: 1578655. (Pubitemid 44544149)
38. Borg R, Vistisen D, Witte DR, Borch-Johnsen K. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study. Diabet Med. 2010;27(8):906-910.
39. Dall TM, Zhang Y, Chen YJ, Quick WW, Yang WG, Fogli J. The Economic Burden Of Diabetes. Heal Aff. 2010;29(2):1-7.
40. Zhang Y, Dall TM, Mann SE, Chen Y, Martin J, Moore V, et al. The economic costs of undiagnosed diabetes. Popul Health Manag. 2009;12 (2):95-101.